Impact of Roux-en-Y Gastric Bypass Limb Length on HbA1c Levels in Obese Individuals with Type 2 Diabetes - Poll - MDSpire

Impact of Roux-en-Y Gastric Bypass Limb Length on HbA1c Levels in Obese Individuals with Type 2 Diabetes

  • By

  • Lena Seidemann

  • Roland Morgenroth

  • Yusef Moulla

  • Undine Gabriele Lange

  • Orestis Lyros

  • Matthias Blüher

  • David Petroff

  • Christiane Prettin

  • Norbert Köhler

  • Arne Dietrich

  • April 21, 2026

  • 0 min

Share

Original Source(s)

Impact of Roux-en-Y Gastric Bypass Limb Length on HbA1c Levels in Obese Individuals with Type 2 Diabetes

  • by Lena Seidemann, Roland Morgenroth, Yusef Moulla, Undine Gabriele Lange, Orestis Lyros, Matthias Blüher, David Petroff, Christiane Prettin, Norbert Köhler, Arne Dietrich

  • April 21, 2026

Related Content

Semaglutide versus placebo in individuals with poor weight loss after bariatric surgery: a double-blinded, randomized, placebo-controlled trial

Semaglutide Linked to NAION Risk

A retrospective database study found a low absolute incidence but higher relative hazard of ischemic optic neuropathy following semaglutide initiation.

Laparoscopic Transcystic Common Bile Duct Exploration for the Treatment of Choledocholithiasis Following Roux-en-Y Gastric Bypass